Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Deucrictibant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharvaris Reports 2024 Financial Results and Business Update
    Pharvaris Reports 2024 Financial Results and Business Update

    07 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/07/3056547/0/en/Pharvaris-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    07 Apr 2025
    Share Share
    Pharvaris: Orphan Designation Granted to Deucrictibant by EU
    Pharvaris: Orphan Designation Granted to Deucrictibant by EU

    01 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/01/3053128/0/en/Pharvaris-Announces-Orphan-Designation-Granted-to-Deucrictibant-by-the-European-Commission.html

    GLOBENEWSWIRE
    01 Apr 2025
    Share Share
    Pharvaris To Present HAE Treatment Data At HAEi Workshop
    Pharvaris To Present HAE Treatment Data At HAEi Workshop

    03 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/03/2957562/0/en/Pharvaris-Announces-Data-Highlighting-Deucrictibant-for-the-Treatment-of-HAE-to-be-Presented-at-the-2024-HAEi-Global-Leadership-Workshop.html

    GLOBENEWSWIRE
    03 Oct 2024
    Share Share
    Pharvaris Provides Business Update And Expands Program
    Pharvaris Provides Business Update And Expands Program

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941176/0/en/Pharvaris-Provides-Business-Update-and-Expands-Development-Program-for-Deucrictibant.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Pharvaris Presents Deucrictibant Data At Bradykinin Symposium
    Pharvaris Presents Deucrictibant Data At Bradykinin Symposium

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941175/0/en/Pharvaris-Presents-Deucrictibant-Long-Term-Extension-Data-for-Both-the-Prophylactic-and-On-Demand-Treatment-of-HAE-at-the-Bradykinin-Symposium-2024.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Pharvaris: Deucrictibant Data Highlights At Recent Conferences
    Pharvaris: Deucrictibant Data Highlights At Recent Conferences

    04 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/04/2892897/0/en/Pharvaris-Highlights-Properties-of-Deucrictibant-in-Data-Presentations-at-Recent-Congresses.html

    GLOBENEWSWIRE
    04 Jun 2024
    Share Share